Interferon-γ and Interleukin-10 Gene Polymorphisms Are Not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression
Overview
Authors
Affiliations
Immunoregulatory cytokines have an influence on hepatitis C virus (HCV) infection outcome. This study aimed to determine whether single nucleotide polymorphisms (SNP) in IFN- γ and IL-10 genes are associated with susceptibility and/or are markers of prognosis regarding chronic hepatitis C outcomes. IFN γ (+874T/A) and IL-10 (-1082G/A) genotypes were determined in 75 HCV genotype 4 patients with different disease severities (chronic hepatitis, n=25, liver cirrhosis and hepatocellular carcinoma (HCC) on top of liver cirrhosis, n=50) and 25 healthy participants using allele-specific polymerase chain reaction. No statistical differences in allele or genotype distributions of IFN γ and IL-10 genes were detected between patients and controls or between patientgroups. No significant difference in the frequency of IL-10 SNP at position -1082 or IFN-γ at position +874T/A was found between chronic HCV genotype 4 and with progression of disease severity in liver cirrhosis or HCC. In conclusion; interferon-γ and interleukin-10 gene polymorphisms are not predictors of disease progression in patients with chronic hepatitis C (Genotype-4).
Dhouioui S, Baroudi S, Zemni I, Mahdhi F, Najjari A, Chelbi H Heliyon. 2024; 10(15):e34852.
PMID: 39166088 PMC: 11333909. DOI: 10.1016/j.heliyon.2024.e34852.
Mei T, Aung H, Tung W, Naing C BMC Cancer. 2023; 23(1):842.
PMID: 37684564 PMC: 10492326. DOI: 10.1186/s12885-023-11323-1.
Zheng M, Li J, Fang W, Luo L, Ding R, Zeng H Front Immunol. 2023; 14:1129767.
PMID: 37122734 PMC: 10140545. DOI: 10.3389/fimmu.2023.1129767.
Gene polymorphisms of inflammatory factors in liver cirrhosis.
Xiao S, Pan X, Huang X, Liu Y, Wen S, Liu A Front Genet. 2023; 14:1140427.
PMID: 37101651 PMC: 10123281. DOI: 10.3389/fgene.2023.1140427.
Dondeti M, Abdelkhalek M, El-Din Elezawy H, Alsanie W, Raafat B, Gamal-Eldeen A J Appl Biomed. 2022; 20(1):37-43.
PMID: 35099129 DOI: 10.32725/jab.2022.001.